CRYSTALLINE FORM OF A NEUROACTIVE STEROID

The disclosure relates to a crystalline solid form of Compound 1. The disclosure also provides methods of preparing said crystalline solid form of Compound 1. L'invention concerne une forme solide cristalline du composé 1. L'invention concerne également des procédés de préparation de ladit...

Full description

Saved in:
Bibliographic Details
Main Authors SHEN, Jianwei, XU, Liuting, WATSON, Paul, CHEN, Cen
Format Patent
LanguageEnglish
French
Published 18.01.2024
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The disclosure relates to a crystalline solid form of Compound 1. The disclosure also provides methods of preparing said crystalline solid form of Compound 1. L'invention concerne une forme solide cristalline du composé 1. L'invention concerne également des procédés de préparation de ladite forme solide cristalline du composé 1.
AbstractList The disclosure relates to a crystalline solid form of Compound 1. The disclosure also provides methods of preparing said crystalline solid form of Compound 1. L'invention concerne une forme solide cristalline du composé 1. L'invention concerne également des procédés de préparation de ladite forme solide cristalline du composé 1.
Author XU, Liuting
CHEN, Cen
WATSON, Paul
SHEN, Jianwei
Author_xml – fullname: SHEN, Jianwei
– fullname: XU, Liuting
– fullname: WATSON, Paul
– fullname: CHEN, Cen
BookMark eNrjYmDJy89L5WTQdA6KDA5x9PHx9HNVcPMP8lXwd1NwVPBzDQ3yd3QO8QxzVQgOcQ3y93ThYWBNS8wpTuWF0twMym6uIc4euqkF-fGpxQWJyal5qSXx4f5GBkYmBoamRgaGjobGxKkCALFkJvM
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate FORME CRISTALLINE D'UN STÉROÏDE NEUROACTIF
ExternalDocumentID WO2024015201A1
GroupedDBID EVB
ID FETCH-epo_espacenet_WO2024015201A13
IEDL.DBID EVB
IngestDate Fri Jul 19 13:06:03 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
French
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_WO2024015201A13
Notes Application Number: WO2023US26138
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240118&DB=EPODOC&CC=WO&NR=2024015201A1
ParticipantIDs epo_espacenet_WO2024015201A1
PublicationCentury 2000
PublicationDate 20240118
PublicationDateYYYYMMDD 2024-01-18
PublicationDate_xml – month: 01
  year: 2024
  text: 20240118
  day: 18
PublicationDecade 2020
PublicationYear 2024
RelatedCompanies SAGE THERAPEUTICS, INC
RelatedCompanies_xml – name: SAGE THERAPEUTICS, INC
Score 3.5120049
Snippet The disclosure relates to a crystalline solid form of Compound 1. The disclosure also provides methods of preparing said crystalline solid form of Compound 1....
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
STEROIDS
Title CRYSTALLINE FORM OF A NEUROACTIVE STEROID
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240118&DB=EPODOC&locale=&CC=WO&NR=2024015201A1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_GFPVtTsWPKQGl4EOxMevaPgzp0pYptB1bnfNpNFkGgszhKv77u5RO97S3JAeXD7jc_ZL7ALgTVD6ymauLuyhhIv6SZq6kZeYOzW2HivnM1YHCcdLpv7ZfJvakBp-bWJgyT-hvmRwRJUqivBflfb38f8QKSt_K1YP4wKGvpyjrBkaFjlE9ocFsBL1uOEiDlBucI24zkmFFs1Hd-YiV9tCQdrQ8hOOejktZbiuVqAH7A-S3KI6hphZNOOSb2mtNOIirL29sVtK3OoF7PnwfZT7C7yQkiN5ikkbEJ4n2xtPOIOOQjNA6TZ-DU7iNwoz3TZxz-rfF6Vu6vUB2BnUE_-ociMotZVHRUdSbtx1XJ0O2mCctJh3PzZm8gNYuTpe7yVdwpLv6SYG6LagX3z_qGpVsIW7Ks1kDOAB7pA
link.rule.ids 230,309,783,888,25576,76882
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_GFOebTsWPqQWl4EOxsduaPgzp0pb60XZsdc6n0mQZCDKHq_jveymd7mlvIQeXS-By90vuA-CaE3FnTalq7iK5gfhLGLkUppHbJO_YhM-mVCUKR3E3fGk_TjqTGnyscmHKOqE_ZXFE1CiB-l6U9_Xi_xHLK2Mrl7f8Hac-74O05-kVOkbzhA6z7vV7_iDxEqYzhrhNj4cVrYPmzkWstIVONlX9DvxxX-WlLNaNSrAH2wPkNy_2oSbnTWiwVe-1JuxE1Zc3DivtWx7ADRu-jVIX4Xfsa4jeIi0JNFeLVTSeCgYZ-9oIvdPkwTuEq8BPWWjgmtnfFrPXZF1A6wjqCP7lMWgyN6VJeFcSZ9a2qSqGbFqOMC1hOzS3xAm0NnE63Uy-hEaYRs8Zyv10BruKpJ4XCG1Bvfj6ludocAt-UZ7TLyvwfpQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=CRYSTALLINE+FORM+OF+A+NEUROACTIVE+STEROID&rft.inventor=SHEN%2C+Jianwei&rft.inventor=XU%2C+Liuting&rft.inventor=WATSON%2C+Paul&rft.inventor=CHEN%2C+Cen&rft.date=2024-01-18&rft.externalDBID=A1&rft.externalDocID=WO2024015201A1